Publications 2019

  1. Al Kahlout RA, Nasrallah GK, Farag EA, Wang L, Lattwein E, Müller MA, El Zowalaty ME, Al Romaihi HE, Graham BS, Al Thani AA, Yassine HM. Comparative serological study for the prevalence of anti-MERS coronavirus antibodies in high- and low-risk groups in Qatar. J Immunol Res 2019:1386740 (2019).
  2. Bartels F, Strönisch T, Farmer K, Rentzsch K, Kiecker F, Finke C. Neuronal autoantibodies assiciated with cognitive impairment in melanoma patients. Ann Oncol 30(5):823-829 (2019).
  3. Borsche M, Hahn S, Hanssen H, Münchau A, Wandinger KP, Brüggemann N. Sez6l2-antibody-associated progressive cerebellar ataxia: a differential diagnosis of atypical parkinsonism. J Neurol. 266(2):522-524 (2019).
  4. De Schaepdryver M, Goossens J, Jeromin A, Brix B, Van Damme P, Poesen K. Analytical performance of a CE-marked immunoassay to quantify phosphorylated neurofilament heavy chains. Clin Chem Lab Med 57(8):e199-e202 (2019).
  5. De Schaepdryver M, Goossens J, de Meyer S, Jeromin A, Masrori P, Brix B, Claeys KG, Schaeverbeke J, Adamczuk K, Vandergerghe R, van Damme P, Poesen K. Serum neurofilament heavy chains as early marker of motor neuron degeneration. Ann Clin Transl Neurol doi: 10.1002/acn3.50890 [Epub] (2019).
  6. Efthymiou G, Dardiotis E, Liaskos C, Marou E, Scheper T, Meyer W, Daponte A, Daoussis D, Hadjigeorgiou G, Bogdanos DP, Sakkas LI. A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis. Clin Immunol 207:87-96 (2019).
  7. Ehlers AM, Blankestijn MA, Knulst AC, Klinge M, Otten HG. Can alternative epitope mapping approaches increase the impact of B-cell epitopes in food allergy diagnostics? Clin Exp Allergy 49(1):17-26 (2019).
  8. Ehlers AM, Klinge M, Suer W, Weimann Y, Knulst AC, Besa F, Le TM, Otten HG. Ara h 7 isoforms share many linear epitopes: Are 3D epitopes crucial to elucidate divergent abilities? Clin Exp Allergy doi: 10.1111/cea.13496 [Epub] (2019).
  9. Ehlers AM, Rossnagel M, Brix B, Blankestijn MA, Le TM, Suer W, Otten HG, Knuslt AC. Sesame oleosins are minor allergens. Clin Tranl Allergy 9:32 (2019).
  10. Emtenani S, Yuan H, Lin C, Pan M, Hundt JE, Schmidt E, Komorowski L, Stanley JR, Hammers CM. Normal human skin is superior to monkey esophagus substrate for detection of circulating BP180-NC16A-specific immunoglobulin G antibodies in bullous pemphigoid. Br J Dermatol 150(5):1099-1106 (2019).
  11. Goletz S, Probst C, Komorowski L, Schlumberger W, Fechner K, van Beek N, Holtsche MM, Recke A, Yancey KB, Hashimoto T, Antonicelli F, Di Zenzo G, Zillikens D, Stöcker W, Schmidt E. A. Sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid. Br J Dermatol 180(1):149-156 (2019).
  12. Heinrich J, Drewniok C, Neugebauer E, Kellner H, Wiegert T. The YoaW signal peptide directs efficient secretion of different heterologous proteins fused to a StrepII-SUMO tag in Bacillus subtilis. Microb Cell Fact 18(1):31 (2019).
  13. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, Lennon VA, Pittock SJ, Klein CJ, McKeon A. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Neurology 93(10):e954-e963 (2019).
  14. Janelidze S, Stomrud E, Brix B, Hansson O. Towards a unified protocol for handling of CSF before beta-amyloid measurements. Alzheimers Res Ther 11(1):63 (2019).
  15. Krauth J, Gerlach S, Marzahl C, Voigt J, Handels H. Synthetic training with gernerative adversarial networks for segmentation of microscopies. In: Handels H, Deserno T, Maier A, Maier-Hein K, Palm C, Tolxdorff T (Hrsg.) Bildverarbeitung für die Medizin 2019. Informatik Aktuell. Springer Vieweg, Wiesbaden, Deutschland, 37-42 (2019).
  16. Lau I, Goletz S, Holtsche MM, Zillikens D, Fechner K, Schmidt E. Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin. J Am Acad Dermatol pii: S0190-9622(19)30522-5 [Epub] (2019).
  17. Lytton SD, Osiecki M, Wozniak M, Cukrowska B, Wierzbicka A, Goliszek M, Socha P, Janczyk W, Dayanakli D, Abendroth D, Kramp S, Fechner K, Scheper T, Mahler M, Bentow C, Bogdanos D, Fuchs D, Woynarowski M. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis. Immunol Res 67(1):39-47 (2019).
  18. Mende M, Borchardt-Lohölter V, Meyer W, Scheper T, Schlumberger W. Autoantibodies in myositis. How to achieve a comprehensive strategy for serological testing. Mediterr J Rheumatol 30(3):155-161 (2019)
  19. Moraes Soane M, Freitas Henriques D, Abreu Lima J, Caricio Martins L, Muigg N, Klemens O, Saschenbrecker S, Schlumberger W, Steinhagen K. Evaluation of a novel IgM screening enzyme-linked immunosorbent assay for sensitive detection of Mayaro virus-infected patients. Microbiol Infect Dis 3(2):1-4 (2019).
  20. Moraes Soane M, Freitas Henriques D, Abreu Lima J, Caricio Martins L, Wilhelm N, Fraune J, Klemens O, Steinhagen K. Novel screening ELISA for sensitive detection of Mayaro virus infected patients. Int J Infect Dis 79(S1):148 (2019).
  21. O’Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A. GABAA receptor autoimmunity: A multicenter experience. Neurol Neuroimmunol Neuroinflamm 6(3):e552 (2019).
  22. Reichert S, Jurianz E, Natalie P, Schlumberger W, Dähnrich C, Johannsen N, Altermann W, Schlaf G, Keyßer G, Schäfer C, Schaller HG, Schulz S. Is periodontitis a prognostic factor in order to indicate antibodies against citrullinated peptides in patients with rheumatoid arthritis? Clin Exp Rheumatol [Epub] (2019).
  23. Royl G, Fokou TJ, Chunder R, Isa R, Münte TF, Wandinger KP, Schwaninger M, Herrmann O, Valdueza JM, Brocke J, Willkomm M, Willemsen D, Auffarth GU, Mindorf S, Brix B, Chamorro A, Planas A, Urra X. Antibodies against neural antigens in patients with acute stroke: joint results of three independent cohort studies. J Neurol doi: 10.1007/s00415-019-09470-2 [Epub] (2019).
  24. Saschenbrecker S, Karl I, Komorowski L, Probst C, Dähnrich C, Fechner K, Stöcker W, Schlumberger W. Serological diagnosis of autoimmune bullous skin diseases. Front Immunol 10:1974 (2019).
  25. Scheurlen KM, Billeter AT, Kopf S, Herbst V, Block M, Nawroth PP, Zeier M, Scherberich JE, Müller-Stich BP. Serum uromodulin and Roux-en-Y gastric bypass: improvement of a marker reflecting nephron mass. Surg Obes Relat Dis pii: S1550-7289(19)30172-8 (2019).
  26. Schumacher M, Rommel FR, Arnetz B, Renz H, Stöcker W, Windhorst A, Hahn A, Neubauer BA. Encephalopathy associated with neurochondrin autoantibodies. J Child Neurol 34(11):660-665 (2019).
  27. Schwenzer A, Quirke AM, Montgomery AB, Venables PJ, Sayles HR, Schlumberger W, Payne JB, Mikuls TR, Midwood KS. Time to include fine specificity anti-citrullinated protein antibodies in routine diagnosis and management of rheumatoid arthritis? Arthritis Rheumatol 71(3):476-478 (2019).
  28. Shelly S, Kryzer TJ, Komorowski L, Miske R, Anderson MD, Flanagan EP, Hinson SR, Lennon VA, Pittock SJ, McKeon A. Neurochondrin neurological autoimmunity. Neurol Neuroimmunol Neuroinflamm 6(6), pii: e612 (2019).
  29. Steubl D, Block M, Herbst V, Nockher WA, Schlumberger W, Kemmner S, Bachmann Q, Angermann S, Wen M, Heemann U, Renders L, Garimella PS, Scherberich J. Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patients. Medicine (Baltimore) 98(21):e15808 (2019).
  30. Stöcker W, Schlumberger W. Alle Beiträge zu den Themen Autoimmundiagnostik und Labordiagnostik der Infektionskrankheiten. In: Gressner A, Arndt T (Hrsg.) Lexikon der Medizinischen Laboratoriumsdiagnostik. 3. Aufl., Springer Medizin Verlag, Heidelberg (2019).
  31. Stricker S, de Laffolie J, Rudloff S, Komorowski L, Zimmer KP. Intracellular localization of microbial transglutaminase and its influence on the transport of gliadin in enterocytes. J Pediatr Gastroenterol Nutr 68(3):e43-e50 (2019).
  32. Uhrlaß S, Wittig F, Koch D, Krüger C, Harder M, Gaajetaan G, Dingemans G, Nenof P. Do the new molecular assays – microarray and realtime polymerase chain reaction – for dermatophyte detection keep what they promise? Hautarzt 70(8):618-626 (2019).
  33. Wald A, Schmidt E, Toberer F, Gutschalk A, Rentzsch K, Enk AH, Hoffmann JHO. Overlap of bullous, anti-laminin-332, and anti-p200 pemphigoid with concomitant anti-contactin-1-positive inflammatory polyneuropathy treated with intravenous immunoglobulins as a manifestation of epitope spreading. JAMA Dermatol 155(5):631-633 (2019).
  34. Warnecke JM, Lattwein E, Saschenbrecker S, Stöcker W, Schlumberger W, Steinhagen K. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections. J Virol Meth 267:8-15 (2019).
  35. Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanangan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ. A multicenter comparison of MOG-IgG cell-based assays. Neurology 92(11):e1250-e1255 (2019).
  36. Xu X, Ren H, Li L, Wang J, Fechner K, Guan H. Anti-Homer-3 antibody associated cerebellar ataxia: A rare case report and literature review. J Neuroimmunol 330:155-158 (2019).
  37. Zelini P, Fornara C, Furione M, Sarasini A, Klemens J, Arossa A, Spinillo A, Gerna G, Lilleri D. Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy. J Clin Virol 120:38-43 (2019).
  38. Grüter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I. Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity.J Neurol. 2019 Nov 22. [Epub ahead of print]
  39. Palmqvist S, Insel PS, Stomrud E, Janelidze S, Zetterberg H, Brix B, Eichenlaub U, Dage JL, Chai X, Blennow K, Mattsson N, Hansson O. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease. EMBO Mol Med. 2019 Nov 11:e11170. [Epub ahead of print]
  40. Dähnrich C, Saschenbrecker S, Gunnarsson I, Schlumberger W, Ronco P, Debiec H. Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy. Kidney International Reports. 2019 Nov 22. [Epub ahead of print]
  1. Bieber K, Harder M, Staender S, Fischer A, Koehler B, Anamueller W, Zillikens D, Ludwig R. Fast and reliable diagnostics for skin infections. 46. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung, München, Deutschland (2019).
  2. Brock J, Herbst V, Block M, Stöcker W. Die Konzentration des Serum-Uromodulin als Indikator der globalen Nierenfunktion. Weltnierentag, Greifswald, Deutschland (2019).
  3. Franke AC, Lindhorst F, Sendscheid O, Steinhagen K. Dried Blood Spots are well-suited specimens for detection of anti-Trypanosoma cruzi antibodies. Annual Meeting of the Association of Public Health Laboratories, St. Louis, USA (2019).
  4. Franke AC, Lindhorst F, Sendscheid O, Steinhagen K. Dried Blood Spots are well-suited specimens for detection of anti-Trypanosoma cruzi antibodies. 71. Annual Scientific Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo, Anaheim, USA (2019).
  5. Gebhardt AK, Klemens O, Sendscheid O, Stiba K, Saschenbrecker S, Steinhagen K. Comparison of enzyme-linked immunosorbent assays for the diagnosis of dengue virus infections. 35. Clinical Virology Symposium of the American Society for Microbilogy, Savannah, USA (2019).
  6. Gebhardt AK, Klemens O, Stiba K, Saschenbrecker S, Steinhagen K. Comparison of enzyme-linked immunosorbent assays for the diagnosis of dengue virus infections. 29. European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Niederlande (2019).
  7. Gebhardt AK, Klemens O, Sendscheid O, Stiba K, Saschenbrecker S, Steinhagen K. Comparison of enzyme-linked immunosorbent assays for the diagnosis of dengue virus infections. 71. Annual Scientific Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo, Anaheim, USA (2019).
  8. Gerlach S, Danckwardt M, Marzahl C, Lederer S, Sendscheid O, Mielke J, Fechner K, Stoecker W, Voigt J. Deep artificial neural networks for pattern recognition in indirect immunofluorescence microscopy 71. Annual Scientific Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo, Anaheim, USA (2019).
  9. Gerlach S, Danckwardt M, Marzahl C, Lederer S, Sendscheid O, Mielke J, Fechner K, Stoecker W, Voigt J. Deep artificial neural networks for pattern recognition in indirect immunofluorescence microscopy. 32. Annual Scientific Meeting of the Association of Medical Laboratory Immunologists, Cleveland, USA (2019).
  10. Hoxha E, Stahl RAK, Brix SR, Witte T, Seebeck F, Schlumberger W, Daehnrich C. Increased sensitivity for PR3-ANCA using a novel chemiluminescence immunoassay. 19. International Vasculitis and ANCA Workshop, Philadelphia, USA (2019).
  11. Honorat JA, Lopez-Chiriboga S, Kryzer TJ, Lennon VA, Komorowski L, Scharf M, Stöcker W, Hinson SR, Pittock SJ, Klein CJ, McKeon A. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  12. Hoxha E, Stahl RAK, Brix SR, Witte T, Seebeck F, Schlumberger W, Daehnrich C. Increased sensitivity for PR3-ANCA using a novel chemiluminescence immunoassay. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  13. Hoxha E, Stahl RAK, Brix SR, Witte T, Seebeck F, Sendscheid O, Schlumberger W, Daehnrich C. Increased sensitivity for PR3-ANCA using a novel chemiluminescence immunoassay. 71. Annual Scientific Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo, Anaheim, USA (2019).
  14. Hoxha E, Stahl RAK, Brix SR, Witte T, Seebeck F, Sendscheid O, Schlumberger W, Daehnrich C. Increased sensitivity for PR3-ANCA using a novel chemiluminescence immunoassay. 32. Annual Scientific Meeting of the Association of Medical Laboratory Immunologists, Cleveland, USA (2019).
  15. Janz J, Ott A, Scheper T, Schlumberger W, Meyer W. Multiparameter assay for the detection of IgA antibodies in autoimmune gastrointestinal diseases. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  16. Janz J, Ott A, Scheper T, Schlumberger W, Meyer W. Multiparameter assay for the detection of IgG antibodies in autoimmune gastrointestinal diseases. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  17. Janz J, Ott A, Scheper T, Schlumberger W, Meyer W. Multiparameter lineblot for autoimmune inflammatory myopathies: Addition of cN-1A for the detection of autoantibodies associated with inclusion body. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  18. Klemens O, Boethfuer J, Wong SJ, Klemens JM, Binnenkade L, Sendscheid O, Steinhagen K. Development of Anti-Powassan ELISA for the detection of specific antibodies based on different antigenic substrates. Annual Meeting of the Association of Public Health Laboratories, St. Louis, USA (2019).
  19. Kühnl A, Dähnrich C, Saschenbrecker S, Gunnarsson I, Ronco P, Debiec H, Schlumberger W. A newly developed chemiluminescence immunoassay improves the detection of anti-PLA2R autoantibodies in primary membranous nephropathy. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  20. Kühnl A, Saschenbrecker S, Komorowski L, Probst C, Pesce G, Schlumberger W, Dähnrich. Novel ELISA to aid the diagnosis of autoimmune gastritis. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  21. Lattwein E, Janku M, Bohm K, Lederer S, Fechner K. Investigation of serological cross-reactivity within the alphavirus genus using IFA BIOCHIP mosaics. 29. European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Niederlande (2019).
  22. Mende M, Meyer W, Scheper T. Laboratory diagnostics of autoantibodies in autoimmune myopathies. 3. Global Conference on Myositis, Berlin, Deutschland (2019).
  23. Miske R, Scharf M, Borchers C, Denno Y, Teegen B, Rochow N, Probst C, Stöcker W, Kermer P, Komorowski L. Identification of RGS8 as an autoantibody target in paraneoplastic cerebellar syndrome. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  24. Miske R, Scharf M, Hahn S, Denno Y, Benkhadra F, Rochow N, Probst C, Teegen B, Stöcker W, Komorowski L. Identification of DAGLA as an autoantibody target in cerebellar or hippocampal degeneration. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  25. Moraes Soane M, Freitas Henriques D, Abreu Lima J, Caricio Martins L, Muigg N, Klemens O, Steinhagen K. Novel screening ELISA for sensitive detection of Mayaro virus-infected patients. 29. European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Niederlande (2019).
  26. Moraes Soane M, Freitas Henriques D, Abreu Lima J, Caricio Martins L, Muigg N, Klemens O, Stiba K, Steinhagen K. Novel screening ELISA for sensitive detection of Mayaro virus-infected patients. 7. Meeting of the European Society for Virology, European Congress of Virology, Rotterdam, Netherlands (2019).
  27. Moraes Soane M, Freitas Henriques D, Abreu Lima J, Caricio Martins L, Muigg N, Sendscheid O, Klemens O, Steinhagen K. Novel screening ELISA for sensitive detection of Mayaro virus-infected patients. 35. Clinical Virology Symposium of the American Society for Microbilogy, Savannah, USA (2019).
  28. Moraes Soane M, Freitas Henriques D, Abreu Lima J, Caricio Martins L, Muigg N, Sendscheid O, Klemens O, Steinhagen K. Novel screening ELISA for sensitive detection of Mayaro virus-infected patients. 71. Annual Scientific Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo, Anaheim, USA (2019).
  29. Pfautsch S, Warnecke JM, Menge B, Klemens O, Klemens JM, Steinhagen K. Sensitive and specific ELISA for the diagnosis of Strongyloides infections. 6. International Congress on Tropical Medicine and Infectious Diseases, Barcelona, Spanien (2019).
  30. Pfautsch S, Warnecke JM, Menge B, Klemens O, Klemens JM, Saschenbrecker S, Steinhagen K. Sensitive and specific ELISA for the diagnosis of Strongyloides infections. 29. European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Niederlande (2019).
  31. Sendscheid O, Meyer W, Scheper T. Laboratory diagnostics of autoantibodies in autoimmune myopathies. 71. Annual Scientific Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo, Anaheim, USA (2019).
  32. Shelly S, Kryzer TJ, Lennon VA, Komorowski L, Miske R, Stöcker W, Anderson MD, Hinson SR, Pittock SJ, McKeon A. Neurochondrin neurological autoimmunity. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  33. Steinhagen K, Muigg N, Warnecke JM, Sendscheid O, Schlumberger W. Testing anti-Zika virus NS1 IgA additionally to IgM increases sensitivity in acutely infected patients from region endemic for flaviviruses. 35. Clinical Virology Symposium of the American Society for Microbilogy, Savannah, USA (2019).
  34. Steinhagen K, Muigg N, Warnecke JM, Sendscheid O, Schlumberger W. Testing anti-Zika virus NS1 IgA additionally to IgM increases sensitivity in acutely infected patients from region endemic for flaviviruses. Annual Meeting of the Association of Public Health Laboratories, St. Louis, USA (2019).
  35. Steinhagen K, Muigg N, Warnecke JM, Schlumberger W. Testing for anti-Zika virus NS1 IgA additionally to IgM increases sensitivity in acutely infected patients from region endemic for flaviviruses. 29. European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Niederlande (2019).
  36. Steinhagen K, Muigg N, Warnecke JM, Sendscheid O, Schlumberger W. Testing anti-Zika virus NS1 IgA additionally to IgM increases sensitivity in acutely infected patients from region endemic for flaviviruses. 71. Annual Scientific Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo, Anaheim, USA (2019).
  37. Stiba K, Borchardt-Lohölter V, Moreira-Soto A, Sener AG, Kaya S, Gómez-Guzmán E, Figueroa-Hernández L, Ziolkowska K, Zakaszewska K, Buska K, Janz J, Ott A, Warnecke JM, Scheper T, Meyer W. Seroprevalence of ten ToRCH infectious pathogens in women residing in Europe and Latin America. 22. Annual Meeting of the European Society for Clinical Virology, Kopenhagen, Dänemark (2019).
  38. Teegen B, Meyer W, Sendscheid O, Kramp SL, Fraune J, Scheper T, Schlumberger W, Stöcker W,  Rentzsch K. Co-occurrence of autoantibodies to DFS70 and autoantibodies associated with rheumatic diseases. 71. Annual Scientific Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo, Anaheim, USA (2019).
  39. Muigg N, Klemens JM, Stiba K, Steinhagen K, Schlumberger W. New diagnostic markers for differentiation of acute and convalescent human cytomegalovirus infections. 7. Meeting of the European Society for Virology, European Congress of Virology, Rotterdam, Netherlands (2019).
  40. Zeng Z, Miske R, Scharf M, Denno Y, Probst C, Stöcker W, Komorowski L. Identification of nine unknown nuclear antigens as autoantibody targets in systemic autoimmune diseases. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  41. Zeng Z, Miske R, Scharf M, Denno Y, Sendscheid O, Probst C, Stoecker W, Komorowski L. UFO-ANA: Cryptic antinuclear autoantibody target antigens revealed. Poster eingereicht bei dem 32. Annual Scientific Meeting of the Association of Medical Laboratory Immunologists, Cleveland, USA (2019).
  1. Arendt P. Fecal calprotectin for diagnosis and management of IBD. MedLab Congress, Dubai, Vereinigte Arabische Emirate (2019).
  2. Arendt P. ATN biomarkers in body fluids - A paradigm shift in the definition of Alzheimer’s. 13th International Congress of the Asian Society Against Dementia and 6th Singapore International Neuro-Cognitive Symposium, Singapur (2019).
  3. Brock J. Determination of autoantibodies in diabetes mellitus type 1. MedLab Congress, Dubai, Vereinigte Arabische Emirate (2019).
  4. Brock J. Mit Erkrankungen der Niere assoziierte Autoantikörper. Weltnierentag, Greifswald, Deutschland (2019).
  5. Cavalar M. PCR-based multiplex detection of most important dermatophytes. A 3-a Conferință a Asociației de Imuno-Dermatologie, Bukarest, Rumänien (2019).
  6. Ens K. Recognition of ANA patterns. The Korean Society for Laboratory Medicine (KSLM) 2019 Spring Symposium, Daegu, Korea (2019).
  7. Fechner K. Microscopy workshop on emerging viruses & microscopy workshop on ANA diagnostic (ICAP), Fortbildung der Medizinischen Universität Innsbruck „Neue Trends in der medizinischen Diagnostik“Wien, Österreich (2019).
  8. Fechner K. ANCA diagnostics – An update. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  9. Grypiotis P. PR3 and PLA2R using the chemiluminescnce technique. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  10. Harder M. Sichere Identifizierung von Pilzspezies mit neuem DNA-Microarray Test in der Praxis. DERM Fachtagung, Frankenthal, Deutschland (2019).
  11. Harder M. Molekulare mykologische Diagnostik in der dermatologischen Praxis. Interaktiver Mittwochs-Workshop (Praxis Prof. Helmbold), Heidelberg, Deutschland (2019).
  12. Jäger D. Development of autoantibody test systems against neural proteins. 13. Göttingen Meeting of the German Neuroscience Society, Göttingen, Deutschland (2019).
  13. Jäger D. Cell-based assays (CBA): Modern technology for diagnostic services. Spring School of Immunology, Kolberg, Polen (2019).
  14. Jäger D. Autoimmune neurological disorders – Biomarkers and diagnostic tools. 6. International Conference “Advances in Clinical Neuroimmunology”, Poznan, Polen (2019).
  15. Krauth J, Gerlach S, Marzahl C, Voigt J, Handels H. Improving semantic segmentation with synthetic image pairs of GANs. Workshop “Bildverarbeitung für die Medizin”, Lübeck, Deutschland (2019).
  16. Langenstroth-Röwer D. Reliable high multiplex testing for sexually transmitted pathogens. MedLab Congress, Dubai, Vereinigte Arabische Emirate (2019).
  17. Langenstroth-Röwer D. New cutting-edge diagnostics for detection and identification of fungi infecting skin, hair or nails. MedLab Congress, Dubai, Vereinigte Arabische Emirate (2019).
  18. Mende M. Optimized diagnostic strategies for ANA diagnostics – ICAP and beyond. Panhellenic Multidiscipline Congress of Autoimmune Diseases, Rheumatology and Clinical Immunology, Pelion, Griechenland (2019).
  19. Mende M. Myositis – Comprehensive multiplex analysis and innovative markers. Panhellenic Multidiscipline Congress of Autoimmune Diseases, Rheumatology and Clinical Immunology, Pelion, Griechenland (2019).
  20. Mende M. Autoimmune neurological disorders – Biomarkers and diagnostic tools. Panhellenic Multidiscipline Congress of Autoimmune Diseases, Rheumatology and Clinical Immunology, Pelion, Griechenland (2019).
  21. Mende M. Fallstricke in der serologischen Diagnostik von SLE. Seminar am Stuttgarter Klinikum, Stuttgart, Deutschland (2019).
  22. Miske R. Autoimmune neurology – From antigen discovery to product development. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  23. Steinhagen K. Novel screening ELISA for sensitive detection of Mayaro virus-infected patients. 29. European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Niederlande (2019).
  24. Ommen G. Uromodulin – A useful biomarker for renal tubular function. IX Congresso Nacional de Patologia Clinica, Lissabon, Portugal (2019).
  25. Rosenstock P. Quality control in laboratory medicine – Challenges in internal and external QC. Seminář Infekční Serologie Erudovaných Laboratoří, Tabor, Tschechien (2019).
  26. Rosenstock P. Chlamydia serology – Challenges and solutions. Seminář Infekční Serologie Erudovaných Laboratoří, Tabor, Tschechien (2019).
  27. Seebeck F. Significance of ANCA testing in the diagnosis of different inflammatory diseases. INOCHEM Autoimmunity Workshop at Centro Médico Dalinde, México City, México (2019).
  28. Seebeck F. Significance of ANCA testing in the diagnosis of different inflammatory diseases. Autoimmunity Workshop at the Unidad de Patologia Clinica, Guadalajara, México (2019).
  29. Seebeck F. Insights into the QC of an IVD-manufacturer. Sistemas Analiticos Workshop on quality control in the autoantibody detection, Lima, Peru (2019).
  30. Seebeck F. Opportunities and limitations of EQA. Sistemas Analiticos Workshop on quality control in the autoantibody detection, Lima, Peru (2019).
  31. Seebeck F. ANCA testing in autoimmune diagnostics. Sistemas Analiticos Workshop on quality control in the autoantibody detection, Lima, Peru (2019).
  32. Sendscheid O. Diagnostic advances in membranous nephropathy. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  33. Stanisak AK. Automation in autoantibody testing. 13. Conference of the Autoantibody Network. Meadowvale, Ontario, Kanada (2019)
  34. Stiba K. Reliable serological diagnosis of WNV infections: helping to combat WNF epidemics. WHO WNV Symposium Diagnosis and Surveillance of West Nile virus Infections in the "One Health" context, Zagreb, Kroatien (2019).
  35. Wetzel S. Precise diagnosis of allergies. International Conference on Allergology and Diagnostics, Riga, Lettland (2019).
  36. Wetzel S. Diagnostische Lücken schließen: Molekulare Allergologie in der täglichen Praxis. Qualitätszirkel, Schwerin, Deutschland (2019).
  37. Wilcke A. Speziesidentifizierung von Dermatomykose-Erregern mittels DNA-Microarray. DVTA-Fortbildung, 11. Dortmunder Mikrobiologie-Tag, Dortmund, Deutschland (2019).
  38. Zeng Z. Identification of nine unknown nuclear antigens as autoantibody targets in systemic autoimmune diseases. 14. Dresden Symposium on Autoantibodies, Dresden, Deutschland (2019).
  39. Ens K. Desafíos para la automatización en la implementación de ICAP. SIMPOSIO SOBRE AUTOINMUNIDAD “Avances en la práctica de laboratorio y clínica, en la adopción de ICAP en Chile”. Santiago, Chile (2019)
  40. Mende M. Optimized test algorithms for the serological diagnostic of autoimmune diseases - ICAP and beyond. NIP, Windhoek, Südafrika (2019)
  41. Mende M. Optimized test algorithms for the serological diagnostic of autoimmune diseases - ICAP and beyond. Alphalab, Oshakati, Namibia (2019)
  42. Mende M, The role of auto-antibodies in the prediction, diagnosis and care of patients with auto-immune diseases. Ampath, Pretoria, Südafrika (2019)
  43. Mende M, Optimized diagnostic strategies, consensus guidelines and recommendations for serological ANA ANCA and APS diagnostics. Lancet, Johannesburg, Südafrika (2019)
  44. Mende M, Myositis comprehensive multiplex analysis and innovative markers. Tygerberg, Capetown, Südafrika (2019)
  45. Mende M, Importance of IFA and challenges of ICAP reporting. Pathcare, Capetown, Südafrika (2019)
  46. Fechner K. ANCA diagnostics – An update. 14. Dresden Symposium on Autoantibodies, Dresden, Germany (2019)
  47. Fechner K. Autoimmune Neurological Diseases – Biomarkers and Diagnostic Tools. XIX Congreso International de Bacteriologia, CNB, Bogota, Columbia (2019)
  48. Fechner K. IFA: Multiplexing and Automation. XIX Congreso International de Bacteriologia, CNB, Bogota, Columbia (2019)
  49. Fechner K. IFA: Multiplexing and Automation. XLIX Congreso National Mexicano de Patologia Clinica, Veracruz, Mexico (2019)
  1. Braasch J, Ostermann S, Mackiewicz M. Antigennachweis von Trichinella. European (1), European (2) and US patent application EP3502685 (filed 2017), EP3502686 (filed 2018) and US2019/0187132 (filed 2019).
  2. Gruhne J, Seismann H, Weimann A. Method for detecting basophil activation. European (1), European (2), Chinese, German and US patent application EP3441763 (filed 2017), EP3441765 (filed 2018), CN109387636A (filed 2018), DE10 2018 006 212 (filed 2018) and US2019/0049461 (filed 2018).
  3. Kaffka C, Rateike M, Stöcker W. Inkubationsvorrichtung sowie System mit Inkubationsvorrichtung und Wipptisch. European and international patent application EP3459636 (filed 2017) and WO2019/057900 (filed 2018).
  4. Herbst V, Hoffmann K. An improved method for diagnosing a fungal infection. European (1), European (2) and US patent application EP3495819 (filed 2017), EP3495820 (filed 2018) and US2019/0178887 (filed 2018).
  5. Komorowski L, Miske R, Venkataraman I, Stöcker W, Probst C, Scharf M, Denno Y, Kade S. Diagnosis of a neuroautoimmune disease. Chinese patent application CN109142740A (filed 2018).
  6. Langenhan J, Probst C. Zellulose-basierter Immunadsorber. European (1) and European patent application (2) EP3477300 (filed 2017) and EP3477301 (filed 2018).
  7. Schulze T, Schröder S, Allerheiligen-Stolzmann S, Buschtez M. Apparatus and method for cleaning of pipetting needles.European, Chinese and US patent application EP3438674 (filed 2017), CN109317441A (filed 2018) and US2019/0041414 (filed 2018).
  8. Steinhagen K, Deerberg A, Lattwein E, Radzimski C, Böthfür J. An immunoassay for the diagnosis of viral infections. European patent application EP3420357 (filed 2017).
  9. Vanmechelen E, De Vos A, Engelborghs S, Peters O, Schipke C. A novel assay for the diagnosis of a neurological disease. European and US patent application EP 3452830 (filed 2017) and US2019/0113527 (filed 2017).
  10. Stöcker W, Pannhoff H, Krause S. Verfahren und Vorrichtung zur Segmentierung und Vereinzelung flächig verteilter Proben mittels Laserschneidens. European and international patent application EP3567362 (filed 2018) and WO 2019/215107 (filed 2019).